Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Saltnes-Lillegård C, Rustøen T, Beitland S, Puntillo K, Hagen M, Hofsø K(2025) Self-reported symptoms in ICU patients and their impact on long-term outcomes-a prospective multicenter study Intensive Care Med(in press) DOI 10.1007/s00134-025-07995-x, PubMed 40586802
Gunnarsdottir G, Rossholt ME, Nordvik T, Wendel K, Aas MF, Skarbø AB, Aulie VS, Stiris T, Ramm-Pettersen A, Pfeiffer HC, Moltu SJ(2025) High dose arachidonic and docosahexaenoic acid in very preterm infants and neurodevelopment at 2 years - A double-blind randomized controlled trial Clin Nutr, 51, 198-205(in press) DOI 10.1016/j.clnu.2025.05.019, PubMed 40580806
Wu X, Parekh P, Lin BD, Pries LK, Guloksuz S, Rutten BPF, Andreassen OA, Linden DEJ, van der Meer D(2025) Exploration of Genetic Overlap of Brain Phenotypes With Schizophrenia: Different Methods Provide Complementary Insights Schizophr Bull(in press) DOI 10.1093/schbul/sbaf096, PubMed 40579369